subscribeSubscribe
Compass gets US FDA fast track for its bispecific DLL4/VEGF-A antibody, CTX-009

Compass gets US FDA fast track for its bispecific DLL4/VEGF-A antibody, CTX-009
PHARMABIZ
27 Apr 2024
Share Share
Gilead gives up on $4.9B antibody magrolimab

Gilead gives up on $4.9B antibody magrolimab
Nick Paul Taylor FIERCE BIOTECH
27 Apr 2024
Share Share
Gilead writes $2.4B off Trodelvy as CEO underscores focus

Gilead writes $2.4B off Trodelvy as CEO underscores focus
Angus Liu FIERCE PHARMA
27 Apr 2024
Share Share
US FDA approves Pfizer`s gene therapy for rare bleeding disorder

US FDA approves Pfizer`s gene therapy for rare bleeding disorder
Sriparna Roy REUTERS
27 Apr 2024
Share Share
Drugmaker AbbVie expects Humira volume erosion to worsen

Drugmaker AbbVie expects Humira volume erosion to worsen
Leroy Leo REUTERS
27 Apr 2024
Share Share
ETH develops AI algorithm for drug discovery based on 3D protein surface

ETH develops AI algorithm for drug discovery based on 3D protein surface
Nicole Raleigh PHARMAPHORUM
26 Apr 2024
Share Share
Sanders presses pharma leaders to change stance on Pandemic Accord proposals

Sanders presses pharma leaders to change stance on Pandemic Accord proposals
Lia DeGroot ENDPTS
26 Apr 2024
Share Share
BioMarin axes 4 candidates, centers R&D around 3 assets

BioMarin axes 4 candidates, centers R&D around 3 assets
Gabrielle Masson FIERCE BIOTECH
26 Apr 2024
Share Share
Gilead Sciences Announces First Quarter 2024 Financial Results

Gilead Sciences Announces First Quarter 2024 Financial Results
PRESS RELEASE
26 Apr 2024
Share Share
Biden administration delays plan to ban menthol cigarettes

Biden administration delays plan to ban menthol cigarettes
REUTERS
26 Apr 2024
Share Share